key: cord-0938683-443c35ir
authors: Ashktorab, Yusuf; Brim, Anas; Pizuorno, Antonio; Gayam, Vijay; Nikdel, Sahar; Brim, Hassan
title: COVID-19 pediatric patients: Gastrointestinal symptoms, presentations, and disparities by race/ethnicity in a large, multi-center United States study
date: 2021-01-06
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.12.078
sha: 1015e9448bf0b3c74038e056ab0cfccea8e2ab6b
doc_id: 938683
cord_uid: 443c35ir

nan

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is currently causing a severe outbreak in the United States and in the world. SARS-CoV-2 mostly causes respiratory and gastrointestinal symptoms (GI) [1] . Clinical manifestations range from common cold to severe disease such as bronchitis, pneumonia, severe acute respiratory syndrome, multi-organ failure and death [2] . SARS-CoV-2 seems to less commonly affect children and to cause less severe disease in this age group. Understanding whether children are affected differently is important for clinical and containment strategies. Also finding the nature of immune responses in children is important given the rare, but severe Multisystem Inflammatory Syndrome in Children (MIS-C) reported in about 1,000 cases worldwide. MIS-C is a recently identified syndrome that appears to be temporally associated with SARS-CoV-2 infection in children [3] . In this study, we describe the clinical presentations, age, sex and gastrointestinal symptoms of children with confirmed SARS-CoV-2 infection.

Search strategy: We conducted a systematic literature search of published articles using electronic databases such as PubMed, OVID, Scopus, and Google Scholar from Jan. 20 th through Nov. 5 th , 2020 using the following terms: COVID-19 Children, COVID-19 Infants, COVID-19 Adolescents, COVID-19 Teenagers, COVID-19 Newborns and COVID-19 Pediatrics. We also searched reference databases from various public health systems such as CDC. Case characteristics were described, including demographics and symptoms ( Figure 1 ). We also included our limited de-identified data from Interfaith Medical Center, a tertiary hospital in Brooklyn, that is affiliated with the State University of New York (SUNY).

Statistical analysis: A total of 6,639 patients' data, from 5 sources [3] [4] [5] [6] , was collected. Symptoms and demographics were combined and analyzed by weighted analysis. The effect of symptoms was reported using weighted analysis where weights were related to the size of the reported study. SPSS v.23 was used for this analysis.

Our study consisted of 6,639 patients from 212 centers in the Unites States ( Figure 1 ). Of our 5 sources, the one that contributed the most to patient data is from Peds COVID-19 Registry (208 hospitals and 6,581 patients). The median age of our cohort was 14.79 years. Males were represented at 51%. Fever was reported in 48% of patients while cough was reported in 35.6% ( Figure 1B) .

Vomiting was the predominant gastrointestinal symptom in our study, reported in 13.2% of the total cohort. This was followed by abdominal pain at 10.1% and diarrhea at 11%. Minorities were well represented in our cohort with 1,974 (29.7%) African Americans and 2,040 (30.7%) Hispanics. While no characterization J o u r n a l P r e -p r o o f of race with symptoms was available from aggregated data, the Interfaith Medical Center COVID-19 patients that were all African Americans displayed diarrhea, nausea and vomiting in 2 out of 3 African American patients (66.6%).

In this study, we describe clinical manifestations of hospitalized COVID-19 US children. The median age in our cohort was 15 years. Most children appear to have mild disease and recover with supportive treatment. There ware slightly more males in our cohort. However, it is not unlikely that gender has an impact on outcome. Clinical presentations in children in our cohorts were largely non-specific with predominance of fever and cough among both genders. With respect to GI symptoms, vomiting was the most prevalent symptom. This matches with other reports from Bolia et al. in which they report that the most prevalent GI symptom for children is vomiting [8] . Worth noting, however, that in our small African American patients' group from Interfaith Medical Center, diarrhea, nausea and abdominal pain were represented at 66.6% (2 out of 3 patients), pointing probably at higher GI manifestations in this minority group. Overall, Hispanic and African American children had higher cumulative rates of COVID-19-associated hospitalizations (16.4 and 10.5 per 100,000, respectively) than White children (2.1 per 100,000) and accounted for two thirds of the registered deaths so far. As such, better prevention and management efforts are needed for minorities to counter risk factors and comorbidities' effects on infection rates and disease outcome. Given the wide variety of clinical symptoms, we recommend clinicians should have a high index of suspicion for SARS-CoV-2 infection in young infants presenting with systemic symptoms, even in the absence of fever. However, as the pandemic continues and children's unlikely receipt of vaccines soon, it is critical for emergency department providers to recognize the various clinical presentations of COVID-19. A more comprehensive evaluation may be warranted in any child presenting with fever in combination with rash, conjunctivitis and/or GI symptoms, regardless of SARS-CoV-2 exposure. This study has the limitation of being a retrospective investigation of a relatively small patients' population. Another limitation is the fact that young children may show signs and symptoms that aren't detected and reported by their guardians and their physicians. As such, the appearance of, and frequency of new symptoms is expected to change as we get more familiar with COVID-19 in children. Also, the large portion of our data is aggregated and did not allow detailed subgroup and race-based analyses. In conclusion, we here report that cough and fever are the primary symptoms in hospitalized pediatric COVID-19 patients in the US. Vomiting, abdominal pain and diarrhea were common among these patients, with vomiting as the most prevalent GI symptom.

J o u r n a l P r e -p r o o f

COVID-19 in Latin America: Symptoms, Morbidities and Gastrointestinal Manifestations. Gastroenterology

COVID-19: Disease, management, treatment, and social impact. The Science of the total environment

Why COVID-19 is less frequent and severe in children: a narrative review

Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children

Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience

Epidemiology, clinical features, and outcomes of hospitalized infants with COVID-19 in the Bronx

Recognising the Gastrointestinal Manifestation of Pediatric Coronavirus Disease